Longeveron Inc. (NASDAQ:LGVN) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET
Company Participants
Devin Blass – CTO & Senior VP of Chemistry, Manufacturing, and Controls
Joshua Michael Hare – Co-Founder, Chief Science Officer & Chairman
Lisa A. Locklear – CFO, Executive VP & Treasurer
Mohamed Wa’el Ahmed Hashad – CEO & Director
Nataliya Agafonova – Chief Medical Officer
Conference Call Participants
Boobalan Pachaiyappan – ROTH Capital Partners, LLC, Research Division
Michael Okunewitch – Maxim Group LLC, Research Division
Raghuram Selvaraju – H.C. Wainwright & Co, LLC, Research Division
Derek Cole – Unidentified Company
Investor Relations – Unidentified Company
Operator
Greetings, and welcome to the Longeveron 2025 Q2 Financial Results and Business Update Call. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Derek Cole, Investor Relations. Thank you. You may begin.
Derek Cole
Thank you, operator. Good afternoon, everyone, and thank you for joining us today to review Longeveron’s 2025 Second Quarter Financial Results and Business Update.
After the U.S. markets closed today, we issued a press release with financial results for Q2 2025, which can be found under the Investors section of the Longeveron website.
On the call today are Wa’el Hashad, Chief Executive Officer; Dr. Joshua Hare, Co-Founder, Chief Science Officer and Chairman of the Board; Nataliya Agafonova, Chief Medical Officer; Lisa Locklear, Chief Financial Officer; and Devin Blass, Chief Technology Officer.
As a reminder, during this call, we will be making forward-looking statements. These statements are subject to certain risks and uncertainties that could cause actual results to differ materially from these statements. Any such statements should be considered in conjunction with cautionary statements in our press releases and risk factors discussed in the company’s filings with the Securities and Exchange Commission, which we encourage you to review.
#Longeveron #LGVN #Earnings #Call #Transcript